Author:
Jácome Fernanda Cunha,Caldas Gabriela Cardoso,Rasinhas Arthur da Costa,de Almeida Ana Luisa Teixeira,de Souza Daniel Dias Coutinho,Paulino Amanda Carlos,Leonardo Raphael,Barth Ortrud Monika,dos Santos Flavia Barreto,Barreto-Vieira Débora Ferreira
Abstract
AbstractDengue (DEN) is the most prevalent arbovirus among humans, and four billion people live at risk of infection. The clinical manifestations of DEN are variable, and the disease may present subclinically or asymptomatically. A quarter of patients develop classical dengue (CD) or severe dengue (SD), which is potentially lethal and involves vascular permeability changes, severe hemorrhage and organ damage. The involvement of the liver is a fairly common feature in DEN, and alterations range from asymptomatic elevation of transaminases to acute liver failure. Since its introduction in Brazil in 1990, two strains of Dengue virus (DENV) serotype 2 (DENV-2) have been detected: Lineage I, which is responsible for an outbreak in 1991, and Lineage II, which caused an epidemic greater than the previous one and had a different epidemiological profile. To date, studies on different strains of the same serotype/genotype and their association with disease severity are scarce. In addition, one of the greatest challenges regarding the study of DEN pathogenesis and the development of drug and vaccine therapies is the absence of an animal model that reproduces the disease as it occurs in humans. The main goals of this study were to assess BALB/c mouse susceptibility experimentally infected by two distinct DENV-2 strains and characterize possible differences in the clinical signs and alterations induced in the liver resulting from those infections. Mice infected by the two DENV-2 lineages gained less weight than uninfected mice; however, their livers were slightly heavier. Increased AST and AST levels were observed in infected mice, and the number of platelets increased in the first 72 h of infection and subsequently decreased. Mice infected with both lineages presented leukocytosis but at different times of infection. The histopathological changes induced by both lineages were similar and comparable to the changes observed in DEN fatal cases. The viral genome was detected in two liver samples. The results demonstrate the susceptibility of BALB/c mice to both DENV-2 lineages and suggest that the changes induced by those strains are similar, although for some parameters, they are manifested at different times of infection.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Instituto Oswaldo Cruz - Fiocruz
Publisher
Springer Science and Business Media LLC
Reference118 articles.
1. World Health Organization. Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases 140 (WHO, 2013).
2. Guzman, M. G. & Harris, E. Dengue. Lancet 385(9966), 453–465. https://doi.org/10.1016/S0140-6736(14)60572-9 (2015).
3. Murray, N. E., Quam, M. B. & Wilder-Smith, A. Epidemiology of dengue: past, present and future prospects. Clin. Epidemiol 5, 299–309. https://doi.org/10.2147/CLEP.S34440 (2013).
4. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496(7446), 504–507. https://doi.org/10.1038/nature12060 (2013).
5. Stanaway, J. D. et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 16(6), 712–723. https://doi.org/10.1016/S1473-3099(16)00026-8 (2016).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献